223 related articles for article (PubMed ID: 29400712)
1. Noncanonical hedgehog pathway activation through SRF-MKL1 promotes drug resistance in basal cell carcinomas.
Whitson RJ; Lee A; Urman NM; Mirza A; Yao CY; Brown AS; Li JR; Shankar G; Fry MA; Atwood SX; Lee EY; Hollmig ST; Aasi SZ; Sarin KY; Scott MP; Epstein EH; Tang JY; Oro AE
Nat Med; 2018 Mar; 24(3):271-281. PubMed ID: 29400712
[TBL] [Abstract][Full Text] [Related]
2. GLI activation by atypical protein kinase C ι/λ regulates the growth of basal cell carcinomas.
Atwood SX; Li M; Lee A; Tang JY; Oro AE
Nature; 2013 Feb; 494(7438):484-8. PubMed ID: 23446420
[TBL] [Abstract][Full Text] [Related]
3. FOXM1 is a downstream target of Gli1 in basal cell carcinomas.
Teh MT; Wong ST; Neill GW; Ghali LR; Philpott MP; Quinn AG
Cancer Res; 2002 Aug; 62(16):4773-80. PubMed ID: 12183437
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase A activation inhibits oncogenic Sonic hedgehog signalling and suppresses basal cell carcinoma of the skin.
Makinodan E; Marneros AG
Exp Dermatol; 2012 Nov; 21(11):847-52. PubMed ID: 23163650
[TBL] [Abstract][Full Text] [Related]
5. Combined inhibition of atypical PKC and histone deacetylase 1 is cooperative in basal cell carcinoma treatment.
Mirza AN; Fry MA; Urman NM; Atwood SX; Roffey J; Ott GR; Chen B; Lee A; Brown AS; Aasi SZ; Hollmig T; Ator MA; Dorsey BD; Ruggeri BR; Zificsak CA; Sirota M; Tang JY; Butte A; Epstein E; Sarin KY; Oro AE
JCI Insight; 2017 Nov; 2(21):. PubMed ID: 29093271
[TBL] [Abstract][Full Text] [Related]
6. Hedgehog signalling mediates drug resistance through targeting TAP1 in hepatocellular carcinoma.
Zhou XT; Ding J; Li HY; Zuo JL; Ge SY; Jia HL; Wu J
J Cell Mol Med; 2020 Apr; 24(7):4298-4311. PubMed ID: 32108992
[TBL] [Abstract][Full Text] [Related]
7. Myocardin/MKL family of SRF coactivators: key regulators of immediate early and muscle specific gene expression.
Cen B; Selvaraj A; Prywes R
J Cell Biochem; 2004 Sep; 93(1):74-82. PubMed ID: 15352164
[TBL] [Abstract][Full Text] [Related]
8. Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours.
Dahmane N; Lee J; Robins P; Heller P; Ruiz i Altaba A
Nature; 1997 Oct; 389(6653):876-81. PubMed ID: 9349822
[TBL] [Abstract][Full Text] [Related]
9. Filamin A interacts with the coactivator MKL1 to promote the activity of the transcription factor SRF and cell migration.
Kircher P; Hermanns C; Nossek M; Drexler MK; Grosse R; Fischer M; Sarikas A; Penkava J; Lewis T; Prywes R; Gudermann T; Muehlich S
Sci Signal; 2015 Nov; 8(402):ra112. PubMed ID: 26554816
[TBL] [Abstract][Full Text] [Related]
10. Expression profiling of serum inducible genes identifies a subset of SRF target genes that are MKL dependent.
Selvaraj A; Prywes R
BMC Mol Biol; 2004 Aug; 5():13. PubMed ID: 15329155
[TBL] [Abstract][Full Text] [Related]
11. Noncanonical regulation of the Hedgehog mediator GLI1 by c-MYC in Burkitt lymphoma.
Yoon JW; Gallant M; Lamm ML; Iannaccone S; Vieux KF; Proytcheva M; Hyjek E; Iannaccone P; Walterhouse D
Mol Cancer Res; 2013 Jun; 11(6):604-15. PubMed ID: 23525267
[TBL] [Abstract][Full Text] [Related]
12. Radiation Sensitization of Basal Cell and Head and Neck Squamous Cell Carcinoma by the Hedgehog Pathway Inhibitor Vismodegib.
Hehlgans S; Booms P; Güllülü Ö; Sader R; Rödel C; Balermpas P; Rödel F; Ghanaati S
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142876
[TBL] [Abstract][Full Text] [Related]
13. Loss of protein kinase Calpha expression may enhance the tumorigenic potential of Gli1 in basal cell carcinoma.
Neill GW; Ghali LR; Green JL; Ikram MS; Philpott MP; Quinn AG
Cancer Res; 2003 Aug; 63(15):4692-7. PubMed ID: 12907651
[TBL] [Abstract][Full Text] [Related]
14. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
[TBL] [Abstract][Full Text] [Related]
15. RAS/MAPK Activation Drives Resistance to Smo Inhibition, Metastasis, and Tumor Evolution in Shh Pathway-Dependent Tumors.
Zhao X; Ponomaryov T; Ornell KJ; Zhou P; Dabral SK; Pak E; Li W; Atwood SX; Whitson RJ; Chang AL; Li J; Oro AE; Chan JA; Kelleher JF; Segal RA
Cancer Res; 2015 Sep; 75(17):3623-35. PubMed ID: 26130651
[TBL] [Abstract][Full Text] [Related]
16. Aberrant activation of hedgehog signaling promotes cell proliferation via the transcriptional activation of forkhead Box M1 in colorectal cancer cells.
Wang D; Hu G; Du Y; Zhang C; Lu Q; Lv N; Luo S
J Exp Clin Cancer Res; 2017 Feb; 36(1):23. PubMed ID: 28148279
[TBL] [Abstract][Full Text] [Related]
17. Molecular Mechanisms of Leukocyte Migration and Its Potential Targeting-Lessons Learned From MKL1/SRF-Related Primary Immunodeficiency Diseases.
Sprenkeler EGG; Guenther C; Faisal I; Kuijpers TW; Fagerholm SC
Front Immunol; 2021; 12():615477. PubMed ID: 33692789
[TBL] [Abstract][Full Text] [Related]
18. AP-1 and TGFß cooperativity drives non-canonical Hedgehog signaling in resistant basal cell carcinoma.
Yao CD; Haensel D; Gaddam S; Patel T; Atwood SX; Sarin KY; Whitson RJ; McKellar S; Shankar G; Aasi S; Rieger K; Oro AE
Nat Commun; 2020 Oct; 11(1):5079. PubMed ID: 33033234
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical visualization of the signature of activated Hedgehog signaling pathway in cutaneous epithelial tumors.
Tanese K; Emoto K; Kubota N; Fukuma M; Sakamoto M
J Dermatol; 2018 Oct; 45(10):1181-1186. PubMed ID: 30035333
[TBL] [Abstract][Full Text] [Related]
20. Substrate stiffness-dependent regulation of the SRF-Mkl1 co-activator complex requires the inner nuclear membrane protein Emerin.
Willer MK; Carroll CW
J Cell Sci; 2017 Jul; 130(13):2111-2118. PubMed ID: 28576971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
